Research powered investment banking
Home
Research
Companies
Themes
Top Picks
Transactions
Events
Redeye
At a Glance
Our Culture
Research & Ratings
Investor Services
Corporate Broking
Corporate Finance
Newsroom
The Team
Careers
FAQ
Governance
Members network
Community
Posts
Investor Scoring
sign in
Member sign in
Join redeye
Home
research
Companies
Themes
Top Picks
Transactions
Events
redeye
About
At a Glance
Our Culture
Research & Ratings
Investor Services
Corporate Broking
Corporate Finance
Newsroom
The Team
Careers
FAQ
Governance
community
Posts
Investor Scoring
The latest from Redeye about Scandinavian Life Science and Technology companies
Bioinvent International
Revealed the BI-1808 target
Moberg Pharma
Completion of recruitment confirms the time plan
Cantargia
Riktad emission ger bränsle för utökad klinisk satsning
Alzinova
Our view of the aducanumab failure
Xspray Pharma
Shaping up to an exciting year
Premium
Top Picks
Attraktiv potential - begränsad risk
Senzime
Får viktig referenskund
Vitrolife
EmbryoScope+ approved in China
XMReality
Follow-up order indicates positive progress
THQ Nordic
To new heights
Artificial Intelligence Seminar 2019
Repris
Systemair
Panasonic - partnerskap med potential
IRLAB Therapeutics
Vi tar sikte på studieresultat i slutet av Q2’19
Transactions
19
Mar
Teqnion AB genomför nyemission inför notering på Nasdaq First North
20
Mar
Cimco Marine genomför företrädesemission
Events
26
Mar
Early Bird
28
Mar
Investor After Work Göteborg
09
Apr
Early Bird
11
Apr
Investor After Work Malmö
23
Apr
Early Bird
25
Apr
Investor After Work Göteborg
Announcements
Redeye söker Jr Redaktör
Redeye söker Projektledare inom Corporate Finance
Redeye sponsrar integrationsprojektet Näringslivet Möter Förorten